Skip to main content
. 2021 Jul 28;2021(7):CD015017. doi: 10.1002/14651858.CD015017.pub2

3.3. Analysis.

3.3

Comparison 3: Ivermectin compared to no treatment for prevention of SARS‐CoV‐2 infection, Outcome 3: All‐cause mortality up to 28 days (primary analysis)